Abiopharma

Clinical trial NCT06970106 updates: 1. completion date: 2028-01-01 → 2029-11-01 2. primary completion date: 2027-12-01 → 2029-10-01 3. enrollment: 18 → 24 participants

Clinical trial NCT05128955 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-12-01 → 2026-04-22 3. primary completion date: 2026-12-01 → 2026-04-22 4. enrollment: 250 → 180 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07554469 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-05-26

Clinical trial NCT07624071 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-03 → 2026-06-04

Clinical trial NCT07480356 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-29

Clinical trial NCT06712823 updates: 1. completion date: 2027-11-01 → 2029-08-01 2. primary completion date: 2027-11-01 → 2029-07-01 3. enrollment: 150 → 200 participants

Clinical trial NCT05326464 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-06-01 → 2025-10-31 3. primary completion date: 2025-06-16 → 2025-02-18 4. enrollment: 17 → 18 participants 5. allocation: NA → NON_RANDOMIZED

Clinical trial NCT05806164 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-07-15 → 2026-08-30

Clinical trial NCT06692881 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-06-01 3. primary completion date: 2026-05-01 → 2026-06-01

Clinical trial NCT05098132: collaborators added: Merck Sharp & Dohme LLC.